Compare Vanguard Intermediate Term Corporate Bond ETF (VCIT) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Intermediate Term Corporate Bond ETF vs 22nd Century Group Inc — how do they compare? Vanguard Intermediate Term Corporate Bond ETF trades at $78.41 (market cap $72.20B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Vanguard Intermediate Term Corporate Bond ETF is far larger — about 116138.8× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 7,532,796). Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Intermediate Term Corporate Bond ETF for 62 Days and 22nd Century Group Inc for 32 Days on average.
| VCIT | XXII | |
|---|---|---|
Market Cap | $72.20B | $621.67K |
Volume | 7,532,796 | 45,625 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $84.82 | $483.00 |
52-Week Low | $77.98 | $0.80 |
Typical Hold Time | 62 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VCIT (Vanguard Intermediate-Term Corporate Bond ETF) trades at $78.48, up 0.27% with a bearish technical signal from moving averages. The ETF offers a 4.8% yield and 5.1% yield-to-maturity with a 6-year duration, positioning it as a core fixed-income holding. Recent institutional buying includes Engineers Gate Manager's $1.27 million purchase and HB Wealth Management increasing holdings by 242.9%.
VCIT presents a compelling risk-return profile for income investors seeking corporate bond exposure with low costs. The 0.03% expense ratio provides cost efficiency versus competitors. Risks include interest rate sensitivity and corporate credit quality concerns. Technical indicators suggest near-term consolidation around $78 support levels.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
